title: Treatment of Alopecia Areata With Tofacitinib.
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.
authors.forename: Omer
authors.initials: O
authors.lastname: Ibrahim
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.
authors.forename: Cheryl B
authors.initials: CB
authors.lastname: Bayart
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.
authors.forename: Sara
authors.initials: S
authors.lastname: Hogan
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.
authors.forename: Melissa
authors.initials: M
authors.lastname: Piliang
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.
authors.forename: Wilma F
authors.initials: WF
authors.lastname: Bergfeld
mesh_terms: D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006197:Hair / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D011127:Polyps; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D012535:Scalp / Q000473:pathology*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; C479163:tofacitinib